Underlying autoimmune diseases are not aggravated during treatment with lenalidomide in patients with mucosa-associated lymphoid tissue lymphoma

Author's reply

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)550
Number of pages1
JournalLeukemia and Lymphoma
Volume56
Issue number2
DOIs
Publication statusPublished - Feb 1 2015

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research
  • Medicine(all)

Cite this

@article{14ed328e94df42e4bfbbeb8815158147,
title = "Underlying autoimmune diseases are not aggravated during treatment with lenalidomide in patients with mucosa-associated lymphoid tissue lymphoma: Author's reply",
author = "Vittorio Montefusco",
year = "2015",
month = "2",
day = "1",
doi = "10.3109/10428194.2014.947979",
language = "English",
volume = "56",
pages = "550",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Taylor and Francis Ltd.",
number = "2",

}

TY - JOUR

T1 - Underlying autoimmune diseases are not aggravated during treatment with lenalidomide in patients with mucosa-associated lymphoid tissue lymphoma

T2 - Author's reply

AU - Montefusco, Vittorio

PY - 2015/2/1

Y1 - 2015/2/1

UR - http://www.scopus.com/inward/record.url?scp=84923932663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923932663&partnerID=8YFLogxK

U2 - 10.3109/10428194.2014.947979

DO - 10.3109/10428194.2014.947979

M3 - Article

VL - 56

SP - 550

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 2

ER -